James Collins, Ph.D.
DirectoratSenti Biosciences Holdings· In proxies 2023–2024
James Collins, Ph.D. is Director of Senti Biosciences Holdings.
Experience
- Senti Biosciences HoldingsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -98%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?